Shedding Light on Nocturnal Movements in Parkinson's Disease: Evidence from Wearable Technologies
Overview
Authors
Affiliations
In Parkinson's disease (PD), abnormal movements consisting of hypokinetic and hyperkinetic manifestations commonly lead to nocturnal distress and sleep impairment, which significantly impact quality of life. In PD patients, these nocturnal disturbances can reflect disease-related complications (e.g., nocturnal akinesia), primary sleep disorders (e.g., rapid eye movement behaviour disorder), or both, thus requiring different therapeutic approaches. Wearable technologies based on actigraphy and innovative sensors have been proposed as feasible solutions to identify and monitor the various types of abnormal nocturnal movements in PD. This narrative review addresses the topic of abnormal nocturnal movements in PD and discusses how wearable technologies could help identify and assess these disturbances. We first examine the pathophysiology of abnormal nocturnal movements and the main clinical and instrumental tools for the evaluation of these disturbances in PD. We then report and discuss findings from previous studies assessing nocturnal movements in PD using actigraphy and innovative wearable sensors. Finally, we discuss clinical and technical prospects supporting the use of wearable technologies for the evaluation of nocturnal movements.
Abnormal arm swing movements in Parkinson's disease: onset, progression and response to L-Dopa.
Patera M, Zampogna A, Pietrosanti L, Asci F, Falletti M, Pinola G J Neuroeng Rehabil. 2025; 22(1):47.
PMID: 40038703 PMC: 11877831. DOI: 10.1186/s12984-025-01589-w.
Commercial symptom monitoring devices in Parkinson's disease: benefits, limitations, and trends.
Rodriguez-Martin D, Perez-Lopez C Front Neurol. 2025; 15:1470928.
PMID: 39764292 PMC: 11700807. DOI: 10.3389/fneur.2024.1470928.
Zhu L, Zhu P, Wang J, Yan K, Zhao S, Jiang Y Front Psychiatry. 2024; 15:1468568.
PMID: 39529898 PMC: 11551719. DOI: 10.3389/fpsyt.2024.1468568.
Cox E, Wade R, Hodgson R, Fulbright H, Phung T, Meader N Health Technol Assess. 2024; 28(30):1-187.
PMID: 39021200 PMC: 11331379. DOI: 10.3310/YDSL3294.
Zampogna A, Borzi L, Rinaldi D, Artusi C, Imbalzano G, Patera M Bioengineering (Basel). 2024; 11(5).
PMID: 38790307 PMC: 11117481. DOI: 10.3390/bioengineering11050440.